Abiola Oladapo

540 total citations
32 papers, 369 citations indexed

About

Abiola Oladapo is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, Abiola Oladapo has authored 32 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Genetics and 4 papers in Nephrology. Recurrent topics in Abiola Oladapo's work include Platelet Disorders and Treatments (8 papers), Hemophilia Treatment and Research (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Abiola Oladapo is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Hemophilia Treatment and Research (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Abiola Oladapo collaborates with scholars based in United States, United Kingdom and Sweden. Abiola Oladapo's co-authors include Karen L. Rascati, Star Khoza, Jamie C. Barner, Paul Gavaza, J. Epstein, Leonard A. Valentino, A. Gringeri, Mei Lü, Shaun Walsh and Jamie O’Hara and has published in prestigious journals such as Blood, Addictive Behaviors and Clinical Therapeutics.

In The Last Decade

Abiola Oladapo

29 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abiola Oladapo United States 10 151 69 60 47 33 32 369
Hanneke Zwikker Netherlands 7 65 0.4× 75 1.1× 35 0.6× 57 1.2× 48 1.5× 11 432
Johan Mesterton Sweden 10 38 0.3× 61 0.9× 90 1.5× 32 0.7× 19 0.6× 25 317
Annelieke Pasma Netherlands 8 69 0.5× 50 0.7× 25 0.4× 35 0.7× 6 0.2× 21 329
Swapna Karkare United States 11 93 0.6× 50 0.7× 17 0.3× 13 0.3× 23 0.7× 25 447
Dana Stafkey-Mailey United States 9 36 0.2× 90 1.3× 41 0.7× 12 0.3× 27 0.8× 28 296
Pamela Landsman‐Blumberg United States 11 51 0.3× 32 0.5× 22 0.4× 55 1.2× 5 0.2× 34 302
Corinne Woods United States 10 17 0.1× 35 0.5× 22 0.4× 38 0.8× 23 0.7× 20 310
Ruzan Avetisyan United States 11 26 0.2× 97 1.4× 39 0.7× 105 2.2× 6 0.2× 12 434
Ritesh Kumar India 4 23 0.2× 27 0.4× 34 0.6× 19 0.4× 37 1.1× 11 304
Neeraj N. Iyer United States 15 214 1.4× 11 0.2× 21 0.3× 12 0.3× 10 0.3× 37 478

Countries citing papers authored by Abiola Oladapo

Since Specialization
Citations

This map shows the geographic impact of Abiola Oladapo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abiola Oladapo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abiola Oladapo more than expected).

Fields of papers citing papers by Abiola Oladapo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abiola Oladapo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abiola Oladapo. The network helps show where Abiola Oladapo may publish in the future.

Co-authorship network of co-authors of Abiola Oladapo

This figure shows the co-authorship network connecting the top 25 collaborators of Abiola Oladapo. A scholar is included among the top collaborators of Abiola Oladapo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abiola Oladapo. Abiola Oladapo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oladapo, Abiola, et al.. (2025). Evaluation of Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Chronic Refractory Gout in the United States. Advances in Therapy. 42(7). 3173–3185. 1 indexed citations
2.
3.
Strand, Vibeke, et al.. (2024). Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis. Rheumatology and Therapy. 11(5). 1271–1290. 2 indexed citations
4.
Rampal, Raajit K., et al.. (2024). Real-Word Effectiveness of Pacritinib in Patients with Myelofibrosis Who Have Thrombocytopenia and Anemia. Blood. 144(Supplement 1). 6649–6649. 1 indexed citations
5.
Oladapo, Abiola, et al.. (2023). Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura. Journal of Patient-Reported Outcomes. 7(1). 68–68. 2 indexed citations
6.
Roberts, Jonathan, et al.. (2021). Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database. Haemophilia. 28(1). 97–108. 7 indexed citations
7.
Oladapo, Abiola, et al.. (2021). Economic Burden Associated with Major Surgery in Patients with von Willebrand Disease: A United States Retrospective Administrative Database Analysis. Journal of Blood Medicine. Volume 12. 699–708. 3 indexed citations
8.
9.
10.
11.
Oladapo, Abiola, Mei Lü, Shaun Walsh, Jamie O’Hara, & Teresa L. Kauf. (2018). Inhibitor clinical burden of disease: a comparative analysis of the CHESS data. Orphanet Journal of Rare Diseases. 13(1). 198–198. 21 indexed citations
12.
Oladapo, Abiola, Shaun Walsh, Jamie O’Hara, & Teresa L. Kauf. (2016). A Descriptive Comparison of Disease Burden Between Hemophilia Patients with and without Inhibitors: Data from the CHESS Study. Blood. 128(22). 4756–4756. 2 indexed citations
13.
Oladapo, Abiola, Jamie C. Barner, Kenneth A. Lawson, et al.. (2014). Medication Effectiveness with the Use of Tumor Necrosis Factor Inhibitors Among Texas Medicaid Patients Diagnosed with Rheumatoid Arthritis. Journal of Managed Care Pharmacy. 20(7). 657–667. 21 indexed citations
14.
Ford, Kentya H., Abiola Oladapo, Kymberle L. Sterling, et al.. (2013). Assessing the psychometric properties of smoking-related attitudes, self-efficacy, and intention among a diverse population of middle school students. Addictive Behaviors. 38(8). 2378–2383. 3 indexed citations
15.
Oladapo, Abiola, Jamie C. Barner, Karen L. Rascati, & Scott A. Strassels. (2012). A Retrospective Database Analysis of Neuropathic Pain and Oral Antidiabetic Medication Use and Adherence Among Texas Adults With Type 2 Diabetes Enrolled in Medicaid. Clinical Therapeutics. 34(3). 605–613. 18 indexed citations
16.
Gavaza, Paul, Karen L. Rascati, Abiola Oladapo, & Star Khoza. (2012). The State of Health Economic Research in South Africa. PharmacoEconomics. 30(10). 925–940. 27 indexed citations
17.
Gavaza, Paul, Karen L. Rascati, Abiola Oladapo, & Star Khoza. (2011). PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA: A SYSTEMATIC REVIEW. Value in Health. 14(3). A19–A19. 1 indexed citations
18.
Barner, Jamie C., Star Khoza, & Abiola Oladapo. (2011). ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Current Medical Research and Opinion. 27(sup2). 13–22. 65 indexed citations
19.
Gavaza, Paul, Karen L. Rascati, Abiola Oladapo, & Star Khoza. (2010). The State of Health Economic Evaluation Research in Nigeria. PharmacoEconomics. 28(7). 539–553. 30 indexed citations
20.
Mathew, Christine, et al.. (2007). Knowledge and perception of health workers towards tele-medicine application in a new teaching hospital in Lagos. Scientific Research and Essays. 2(1). 16–19. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanneke Zwikker Breakdown of academic impact, for papers by Johan Mesterton Breakdown of academic impact, for papers by Annelieke Pasma Breakdown of academic impact, for papers by Swapna Karkare Breakdown of academic impact, for papers by Dana Stafkey-Mailey Breakdown of academic impact, for papers by Pamela Landsman‐Blumberg Breakdown of academic impact, for papers by Corinne Woods Breakdown of academic impact, for papers by Ruzan Avetisyan Breakdown of academic impact, for papers by Ritesh Kumar Breakdown of academic impact, for papers by Neeraj N. Iyer
Rankless by CCL
2026